Extracellular activation of arginase-1 decreases enterocyte inducible nitric oxide synthase activity during systemic inflammation

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 297, Issue 4, 2009, Pages

  Miki, Keita ^a   Kumar, Abhai ^a   Yang, Runkuan ^a   Killeen, Meaghan E ^a   Delude, Russell L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Liver damage; Shock; Systemic inflammatory response syndrome

Indexed keywords

ARGINASE 1; BIOTIN; INDUCIBLE NITRIC OXIDE SYNTHASE; ARG1 PROTEIN, MOUSE; ARGINASE; AUTACOID; ENZYME INHIBITOR; GAMMA INTERFERON; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NOS2 PROTEIN, HUMAN; NOS2 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STIMULATION; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INFLAMMATION; INTESTINE CELL; LIVER CYTOSOL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CACO 2 CELL LINE; CHEMICALLY INDUCED; DISEASE MODEL; DOWN REGULATION; DRUG EFFECTS; ENZYMOLOGY; IMMUNOLOGY; LIVER; METABOLISM; PROTEIN MULTIMERIZATION; PROTEIN PROCESSING; TIME; WESTERN BLOTTING;

ANIMALS; ARGINASE; BLOTTING, WESTERN; CACO-2 CELLS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENTEROCYTES; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN MULTIMERIZATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349748530     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.90716.2008     Document Type: Article

References (43)

1. Baek KJ, Thiel BA, Lucas S, Stuehr DJ. Macrophage nitric oxide synthase subunits. Purification, characterization, and role of prosthetic groups and substrate in regulating their association into a dimeric enzyme. J Biol Chem 268: 21120-21129, 1993. (Pubitemid 23292298)
2. Barbul A. Arginine: biochemistry, physiology, and therapeutic implications. JPEN J Parenter Enteral Nutr 10: 227-238, 1986. (Pubitemid 16134871)
3. Barbul A, Uliyargoli A. Use of exogenous arginine in multiple organ dysfunction syndrome and sepsis. Crit Care Med 35: S564-S567, 2007. (Pubitemid 47312196)
4. Berkowitz DE, White R, Li D, Minhas KM, Cernetich A, Kim S, Burke S, Shoukas AA, Nyhan D, Champion HC, Hare JM. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 108: 2000-2006, 2003. (Pubitemid 37296546)
5. Beruter J, Colombo JP, Bachmann C. Purification and properties of arginase from human liver and erythrocytes. Biochem J 175: 449-454, 1978. (Pubitemid 9060102)
6. Bronte V, Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 5: 641-654, 2005. (Pubitemid 41113195)
7. Chavez AM, Menconi MJ, Hodin RA, Fink MP. Cytokine-induced intestinal epithelial hyperpermeability: role of nitric oxide. Crit Care Med 27: 2246-2251, 1999. (Pubitemid 29508346)
8. Colleluori DM, Ash DE. Classical and slow-binding inhibitors of human type II arginase. Biochemistry 40: 9356-9362, 2001. (Pubitemid 32730058)
9. Deitch EA. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg 125: 403-404, 1990.
10. Durante W, Johnson FK, Johnson RA. Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 34: 906-911, 2007. (Pubitemid 47083958)
11. Eckmann L, Laurent F, Langford TD, Hetsko ML, Smith JR, Kagnoff MF, Gillin FD. Nitric oxide production by human intestinal epithelial cells and competition for arginine as potential determinants of host defense against the lumen-dwelling pathogen Giardia lamblia. J Immunol 164: 1478-1487, 2000. (Pubitemid 30067264)
12. Fink MP, Delude RL. Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin 21: 177-196, 2005.
13. Galeva N, Altermann M. Comparison of one-dimensional and twodimensional gel electrophoresis as a separation tool for proteomic analysis of rat liver microsomes: cytochromes P450 and other membrane proteins. Proteomics 2: 713-722, 2002. (Pubitemid 34693572)
14. Gobert AP, Cheng Y, Akhtar M, Mersey BD, Blumberg DR, Cross RK, Chaturvedi R, Drachenberg CB, Boucher JL, Hacker A, Casero RA Jr, Wilson KT. Protective role of arginase in a mouse model of colitis. J Immunol 173: 2109-2117, 2004. (Pubitemid 38971649)
15. Houdijk AP, Teerlink T, Visser JJ, van Lambalgen AA, van Leeuwen PA. Arginine deficiency in bile duct-ligated rats after surgery: the role of plasma arginase and gut endotoxin restriction. Gastroenterology 113: 1375-1383, 1997. (Pubitemid 27418992)
16. Huber-Lang M, Sarma VJ, Lu KT, McGuire SR, Padgaonkar VA, Guo RF, Younkin EM, Kunkel RG, Ding J, Erickson R, Curnutte JT, Ward PA. Role of C5a in multiorgan failure during sepsis. J Immunol 166: 1193-1199, 2001. (Pubitemid 32060279)
17. Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst P, Snyder SH. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol 3: 193-197, 2001.
18. Kalil AC, Danner RL. L-Arginine supplementation in sepsis: beneficial or harmful? Curr Opin Crit Care 12: 303-308, 2006.
19. Kanai S, Honda T, Uehara T, Matsumoto T. Liver function tests in patients with bacteremia. J Clin Lab Anal 22: 66-69, 2008. (Pubitemid 351272483)
20. Lee J, Ryu H, Ferrante RJ, Morris SM Jr, Ratan RR. Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Proc Natl Acad Sci USA 100: 4843-4848, 2003. (Pubitemid 36457816)
21. Louis CA, Reichner JS, Henry WL Jr, Mastrofrancesco B, Gotoh T, Mori M, Albina JE. Distinct arginase isoforms expressed in primary and transformed macrophages: regulation by oxygen tension. Am J Physiol Regul Integr Comp Physiol 274: R775-R782, 1998. (Pubitemid 28158330)
22. Luiking YC, Poeze M, Dejong CH, Ramsay G, Deutz NE. Sepsis: an arginine deficiency state? Crit Care Med 32: 2135-2145, 2004. (Pubitemid 39372550)
23. Mori M. Regulation of nitric oxide synthesis and apoptosis by arginase and arginine recycling. J Nutr 137: 1616S-1620S, 2007. (Pubitemid 46855520)
24. Mori M, Gotoh T. Regulation of nitric oxide production by arginine metabolic enzymes. Biochem Biophys Res Commun 275: 715-719, 2000. (Pubitemid 30708226)
25. Morin MJ, Unno N, Hodin RA, Fink MP. Differential expression of inducible nitric oxide synthase messenger RNA along the longitudinal and crypt-villus axes of the intestine in endotoxemic rats. Crit Care Med 26: 1258-1264, 1998. (Pubitemid 28334982)
26. Morris S. Regulation of arginine availability and its impact on NO synthesis. In: Nitric Oxide Biology and Pathobiology, edited by Ignarro LJ. Los Angeles, CA: Academic, 2005, p. 187-197.
27. Murayama H, Ikemoto M, Fukuda Y, Nagata A. Superiority of serum type-I arginase and ornithine carbamyltransferase in the detection of toxicant-induced acute hepatic injury in rats. Clin Chim Acta 391: 31-35, 2008.
28. Nijveldt RJ, Siroen MP, van der Hoven B, Teerlink T, Prins HA, Girbes AR, van Leeuwen PA. High plasma arginine concentrations in critically ill patients suffering from hepatic failure. Eur J Clin Nutr 58: 587-593, 2004. (Pubitemid 38500128)
29. Ochoa JB, Bernard AC, O'Brien WE, Griffen MM, Maley ME, Rockich AK, Tsuei BJ, Boulanger BR, Kearney PA, Morris SM Jr. Arginase I expression and activity in human mononuclear cells after injury. Ann Surg 233: 393-399, 2001. (Pubitemid 32187819)
30. Oismuller C, Mayer N, Micksche M, Steltzer H, Hammerle AF. In vivo modulation of human neutrophil function by pentoxifylline in patients with septic syndrome. Shock 4: 161-165, 1995.
31. Rumbo M, Courjault-Gautier F, Sierro F, Sirard JC, Felley-Bosco E. Polarized distribution of inducible nitric oxide synthase regulates activity in intestinal epithelial cells. FEBS J 272: 444-453, 2005.
32. Salzman AL, Eaves-Pyles T, Linn SC, Denenberg AG, Szabo C. Bacterial induction of inducible nitric oxide synthase in cultured human intestinal epithelial cells. Gastroenterology 114: 93-102, 1998. (Pubitemid 28020959)
33. Santhanam L, Lim HK, Miriel V, Brown T, Patel M, Balanson S, Ryoo S, Anderson M, Irani K, Khanday F, Di Costanzo L, Nyhan D, Hare JM, Christianson DW, Rivers R, Shoukas A, Berkowitz DE. Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction. Circ Res 101: 692-702, 2007. (Pubitemid 47494100)
34. Sonoki T, Nagasaki A, Gotoh T, Takiguchi M, Takeya M, Matsuzaki H, Mori M. Coinduction of nitric-oxide synthase and arginase I in cultured rat peritoneal macrophages and rat tissues in vivo by lipopolysaccharide. J Biol Chem 272: 3689-3693, 1997. (Pubitemid 27066877)
35. Spain DA, Wilson MA, Bar-Natan MF, Garrison RN. Role of nitric oxide in the small intestinal microcirculation during bacteremia. Shock 2: 41-46, 1994.
36. Tadie JM, Henno P, Leroy I, Danel C, Naline E, Faisy C, Riquet M, Levy M, Israel-Biet D, Delclaux C. Role of nitric oxide synthase/arginase balance in bronchial reactivity in patients with chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 294: L489-L497, 2008.
37. Unno N, Wang H, Menconi MJ, Tytgat SH, Larkin V, Smith M, Morin MJ, Chavez A, Hodin RA, Fink MP. Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology 113: 1246-1257, 1997. (Pubitemid 27418978)
38. Vincendeau P, Gobert AP, Daulouede S, Moynet D, Mossalayi MD. Arginases in parasitic diseases. Trends Parasitol 19: 9-12, 2003.
39. Vodovotz Y. Modified microassay for serum nitrite and nitrate. Biotechniques 20: 390-392, 394, 1996. (Pubitemid 26080871)
40. Vodovotz Y, Bogdan C, Paik J, Xie QW, Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J Exp Med 178: 605-613, 1993. (Pubitemid 23218209)
41. Wang SR. Method for protecting against endotoxin-induced shock using ornithine, edited by USPTO. US Patent 5,686,493. Nov. 11, 1997.
42. Witthoft T, Eckmann L, Kim JM, Kagnoff MF. Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells. Am J Physiol Gastrointest Liver Physiol 275: G564-G571, 1998. (Pubitemid 28439732)
43. Zhang C, Hein TW, Wang W, Miller MW, Fossum TW, McDonald MM, Humphrey JD, Kuo L. Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles. Hypertension 44: 935-943, 2004. (Pubitemid 39577425)